New Frontiers in the Design and Synthesis of Imaging Probes for PET Oncology: Current Challenges and Future Directions

被引:30
作者
Smith, Graham [2 ]
Carroll, Laurence [1 ]
Aboagye, Eric O. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Comprehens Canc Imaging Ctr, Fac Med, London W12 0NN, England
[2] Univ Hull, Postgrad Med Inst, Kingston Upon Hull HU6 7RX, N Humberside, England
关键词
Positron emission tomography; Probe development; Therapy monitoring; F-18]FDG; COPPER-FREE CLICK; IN-VITRO; POSITRON; APOPTOSIS; CANCER; HYPOXIA; PROLIFERATION; THERAPY; TUMORS; TRACER;
D O I
10.1007/s11307-012-0590-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Despite being developed over 30 years ago, 2-deoxy-2-[F-18]fluoro-d-glucose remains the most frequently used radiotracer in PET oncology. In the last decade, interest in new and more specific radiotracers for imaging biological processes of oncologic interest has increased exponentially. This review summarizes the strategies underlying the development of those probes together with their validation and status of clinical translation; a brief summary of new radiochemistry strategies applicable to PET imaging is also included. The article finishes with a consideration of the challenges imaging scientists must overcome to bring about increased adoption of PET as a diagnostic or pharmacologic tool.
引用
收藏
页码:653 / 666
页数:14
相关论文
共 92 条
[1]   The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture [J].
Aboagye, E. O. .
BRITISH JOURNAL OF RADIOLOGY, 2010, 83 (994) :814-822
[2]  
Allen AM., 2012, Eur J Nucl Med Mol Imaging
[3]   Imaging of cell proliferation: Status and prospects [J].
Bading, James R. ;
Shieds, Anthony F. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 :64S-80S
[4]   Synthesis of [11C-carbonyl]hydroxyureas by a rhodium-mediated carbonylation reaction using [11C]carbon monoxide [J].
Barletta, Julien ;
Karimi, Farhad ;
Langstrom, Bengt .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (05) :429-436
[5]   In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography [J].
Barthel, H ;
Wilson, H ;
Collingridge, DR ;
Brown, G ;
Osman, S ;
Luthra, SK ;
Brady, F ;
Workman, P ;
Price, PM ;
Aboagye, EO .
BRITISH JOURNAL OF CANCER, 2004, 90 (11) :2232-2242
[6]   Copper-free click chemistry for dynamic in vivo imaging [J].
Baskin, Jeremy M. ;
Prescher, Jennifer A. ;
Laughlin, Scott T. ;
Agard, Nicholas J. ;
Chang, Pamela V. ;
Miller, Isaac A. ;
Lo, Anderson ;
Codelli, Julian A. ;
Bertozzi, Carolyn R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) :16793-16797
[7]   Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αvβ3-Integrin and αvβ5-Integrin Imaging Agent [J].
Battle, Mark R. ;
Goggi, Julian L. ;
Allen, Lucy ;
Barnett, Jon ;
Morrison, Matthew S. .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (03) :424-430
[8]   In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)-Glucose Conjugate for Hypoxia Imaging [J].
Bayly, Simon R. ;
King, Robert C. ;
Honess, Davina J. ;
Barnard, Peter J. ;
Betts, Helen M. ;
Holland, Jason P. ;
Hueting, Rebekka ;
Bonnitcha, Paul D. ;
Dilworth, Jonathan R. ;
Aigbirhio, Franklin I. ;
Christlieb, Martin .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) :1862-1868
[9]   Immuno-PET of Cancer: A Revival of Antibody Imaging [J].
Boerman, Otto C. ;
Oyen, Wim J. G. .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) :1171-1172
[10]   Copper-free click chemistry with the short-lived positron emitter fluorine-18 [J].
Bouvet, Vincent ;
Wuest, Melinda ;
Wuest, Frank .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2011, 9 (21) :7393-7399